Ahmed Ehab Salem (Ahmed Salem)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 8

Top Topics

Diffuse Large B Cell Lymphoma

Kidney Transplantation

Mechanical Ventilation

Top Venues

Human vaccines & immunotherapeutics

PharmacoEconomics - open

This page only lists publications with an associated author ORCID identifier.

Publications

Ahmed Ehab Salem, Elizabeth M La, Desmond Curran, Brandon J Patterson, Justin Carrico, Stéphane Lorenc, Katherine A Hicks, Sara Poston, Christopher F Carpenter
Cost-Effectiveness of Recombinant Zoster Vaccine for the Prevention of Herpes Zoster in Hematopoietic Stem Cell Transplant Recipients and Other Immunocompromised Adults in the United States. PharmacoEconomics - open (2023)
Desmond Curran, Brandon J Patterson, Justin Carrico, Ahmed Ehab Salem, Elizabeth M La, Stéphane Lorenc, Katherine A Hicks, Sara Poston, Christopher F Carpenter
Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer. Human vaccines & immunotherapeutics (2023)
Desmond Curran, Brandon J Patterson, Justin Carrico, Ahmed Ehab Salem, Elizabeth M La, Stéphane Lorenc, Katherine A Hicks, Sara Poston, Christopher F Carpenter
Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer. Human vaccines & immunotherapeutics 19 (1) (2023)
Desmond Curran, Brandon J Patterson, Justin Carrico, Ahmed Ehab Salem, Elizabeth M La, Stéphane Lorenc, Katherine A Hicks, Sara Poston, Christopher F Carpenter
Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer. Human vaccines & immunotherapeutics 19 (1) (2023)
Desmond Curran, Brandon J Patterson, Justin Carrico, Ahmed Ehab Salem, Elizabeth M La, Stéphane Lorenc, Katherine A Hicks, Sara Poston, Christopher F Carpenter
Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer. Human vaccines & immunotherapeutics 19 (1) (2023)
Desmond Curran, Brandon J Patterson, Justin Carrico, Ahmed Ehab Salem, Elizabeth M La, Stéphane Lorenc, Katherine A Hicks, Sara Poston, Christopher F Carpenter
Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer. Human vaccines & immunotherapeutics 19 (1) (2023)
Desmond Curran, Elizabeth M La, Ahmed Ehab Salem, David Singer, Nicolas Lecrenier, Sara Poston
Modeled impact of the COVID-19 pandemic and associated reduction in adult vaccinations on herpes zoster in the United States. Human vaccines & immunotherapeutics 18 (1) (2022)
Desmond Curran, Désirée A M van Oorschot, Sean Matthews, Johannes Hain, Ahmed Ehab Salem, Magdalena Schwarz
Long-term efficacy data for the recombinant zoster vaccine: impact on public health and cost effectiveness in Germany. Human vaccines & immunotherapeutics 17 (12) (2021)